SinoMab BioScience Limited — Capital/Financing Update 2019

Oct 25, 2019

PHIP

	SinoMab BioScience Limited - B
	YOU SHOULD READ THE WARNING IN THE DOCUMENT.

 

►	Warning
►	Important
►	Expected Timetable
►	Contents
►	Summary
►	Definitions
►	Glossary of Technical Terms
►	Forward-looking Statements
►	Risk Factors
►	Waivers from Strict Compliance with the Listing Rules and Exemptions from Compliance with the Companies (Winding Up and Miscellaneous Provisions) Ordinance
►	Information about this Prospectus and the Global Offering
►	Directors and Parties Involved in the Global Offering
►	Corporate Information
►	Industry Overview
►	Regulatory Overview
►	History, Development and Group Structure
►	Business
►	Relationship with Our Controlling Shareholders
►	Connected Transactions
►	Directors and Senior Management
►	Substantial Shareholders
►	Share Capital
►	Financial Information
►	Cornerstone Investors
►	Future Plans and Use of Proceeds
►	Underwriting
►	Structure of the Global Offering
►	How to Apply for Hong Kong Offer Shares
►	Appendix I - Accountants' Report
►	Appendix II - Unaudited Pro Forma Financial Information
►	Appendix III - Summary of the Articles of Association
►	Appendix IV - Statutory and General Information
►	Appendix V - Documents Delivered to the Registrar of Companies and Available for Inspection